In eight studies, the experiences involved the taking of GLP‐1 RAs with either a current or previous prescription, six of these as a T2DM treatment [27, 29, 34, 35, 36, 40], one as an adjunct to insulin for T1DM [31], and one for multiple indications [26]. This evidence concerns the gene INS and type 1 diabetes mellitus.